[go: up one dir, main page]

MX2012005733A - Metodo de produccion de derivados de acido glutamico marcados con f-18. - Google Patents

Metodo de produccion de derivados de acido glutamico marcados con f-18.

Info

Publication number
MX2012005733A
MX2012005733A MX2012005733A MX2012005733A MX2012005733A MX 2012005733 A MX2012005733 A MX 2012005733A MX 2012005733 A MX2012005733 A MX 2012005733A MX 2012005733 A MX2012005733 A MX 2012005733A MX 2012005733 A MX2012005733 A MX 2012005733A
Authority
MX
Mexico
Prior art keywords
glutamic acid
acid derivatives
production
labeled glutamic
labeled
Prior art date
Application number
MX2012005733A
Other languages
English (en)
Inventor
Thomas Brumby
Mathias Berndt
Heribert Schmitt-Willich
Matthias Friebe
Keith Graham
Christina Hultsch
Hans-Juergen Wester
Franzisca Wagner
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of MX2012005733A publication Critical patent/MX2012005733A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C07C227/20—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)

Abstract

Métodos que permiten obtener derivados de ácido glutámico marcados con F-18.
MX2012005733A 2009-11-17 2010-11-06 Metodo de produccion de derivados de acido glutamico marcados con f-18. MX2012005733A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09075508 2009-11-17
PCT/EP2010/006766 WO2011060887A2 (en) 2009-11-17 2010-11-06 Method for production of f-18 labeled glutamic acid derivatives

Publications (1)

Publication Number Publication Date
MX2012005733A true MX2012005733A (es) 2013-01-22

Family

ID=43933363

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012005733A MX2012005733A (es) 2009-11-17 2010-11-06 Metodo de produccion de derivados de acido glutamico marcados con f-18.

Country Status (15)

Country Link
US (1) US20130149243A1 (es)
EP (1) EP2501663A2 (es)
JP (1) JP2013510891A (es)
KR (1) KR20120101452A (es)
CN (1) CN102712552B (es)
AR (1) AR080670A1 (es)
AU (1) AU2010321278B2 (es)
BR (1) BR112012011786A2 (es)
CA (1) CA2780930A1 (es)
HK (1) HK1177928A1 (es)
IL (1) IL219698A0 (es)
MX (1) MX2012005733A (es)
RU (1) RU2012124810A (es)
TW (1) TW201121572A (es)
WO (1) WO2011060887A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6055417B2 (ja) 2010-12-09 2016-12-27 ジーイー・ヘルスケア・リミテッド 放射性トレーサー組成物
EP2520557A1 (en) * 2011-05-03 2012-11-07 Bayer Pharma Aktiengesellschaft Novel precursors of glutamate derivatives
US9546193B2 (en) 2013-10-24 2017-01-17 The Regents Of The University Of California Compositions and methods for 18F-fluorodeoxyglycosylamines
CN113019279A (zh) * 2021-03-11 2021-06-25 山西医科大学第一医院 一种放射性药物制备的自动合成装置及其使用方法
WO2023229997A1 (en) * 2022-05-23 2023-11-30 Board Of Regents, The University Of Texas System Cgmp-compliant automated [18f]fspg production for clinical examination

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774243B2 (en) * 1999-08-24 2004-08-10 Agouron Pharmaceuticals, Inc. Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
EP1314041A2 (en) * 2000-09-01 2003-05-28 Annovis, Inc. Screen for glutamate reuptake inhibitors, stimulators, and modulators
AU2003304200B2 (en) * 2002-08-02 2009-10-01 Vrije Universiteit Brussel Radioactively labelled amino acid analogues, their preparation and use
GB0422004D0 (en) * 2004-10-05 2004-11-03 Amersham Plc Method of deprotection
EP1923382A1 (de) * 2006-11-18 2008-05-21 Bayer Schering Pharma Aktiengesellschaft [F-18] markierte L-Glutaminsäure, [F-18] markiertes Glutamin, ihre Derivate und ihre Verwendung sowie Verfahren zu ihrer Herstellung
EP2123621A1 (de) * 2008-05-20 2009-11-25 Bayer Schering Pharma Aktiengesellschaft Neue {F-18}-markierte L-Glutaminsäure- und L-Glutaminderivate (I), ihre Verwendung sowie Verfahren zu ihrer Herstellung
NZ576582A (en) * 2006-11-01 2011-12-22 Bayer Schering Pharma Ag [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
EP2123619A1 (de) * 2008-05-20 2009-11-25 Bayer Schering Pharma AG Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung
EP2123620A1 (en) * 2008-05-20 2009-11-25 Bayer Schering Pharma Aktiengesellschaft {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them
JP2011526267A (ja) * 2008-07-03 2011-10-06 バイエル ファーマ アクチエンゲゼルシャフト 化合物および放射性医薬品の製造方法

Also Published As

Publication number Publication date
IL219698A0 (en) 2012-07-31
AU2010321278B2 (en) 2014-08-14
KR20120101452A (ko) 2012-09-13
EP2501663A2 (en) 2012-09-26
HK1177928A1 (en) 2013-08-30
WO2011060887A3 (en) 2012-04-12
JP2013510891A (ja) 2013-03-28
TW201121572A (en) 2011-07-01
AU2010321278A1 (en) 2012-05-31
WO2011060887A2 (en) 2011-05-26
BR112012011786A2 (pt) 2019-09-24
CN102712552B (zh) 2015-07-22
US20130149243A1 (en) 2013-06-13
WO2011060887A8 (en) 2011-10-20
AR080670A1 (es) 2012-05-02
RU2012124810A (ru) 2013-12-27
CA2780930A1 (en) 2011-05-26
CN102712552A (zh) 2012-10-03

Similar Documents

Publication Publication Date Title
EA201300074A1 (ru) Способ получения представляющего интерес соединения
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
EP2290092A4 (en) PROCESS FOR PRODUCTION OF L-AMINO ACID
MX2012014117A (es) Metodo para la produccion de ligandos beta amiloide marcados con 18f.
CL2009000503A1 (es) Proceso de preparacion de compuestos derivados de acido 2-amino-5-cianobenzoico-3-sustituidos o 1h-pirazol-5-carboxamida.
PL2180052T3 (pl) Sposób wytwarzania L-lizyny
IN2012DN02707A (es)
CL2012002082A1 (es) Proceso para la preparacion de lacosamida, por hidroximetilación; compuestos intermediarios.
BR112012029985A2 (pt) métodos de determinação de rotatividade beta-amiloide no sangue.
EP2471943A4 (en) PROCESS FOR THE PREPARATION OF L-AMINO ACID
EP2128263A4 (en) PROCESS FOR PRODUCING L-AMINO ACID
CL2012000493A1 (es) Procedimiento de preparacion de 2-alquilamino-3-piridin-n-bencilpiperazin cetonas.
MX2012005733A (es) Metodo de produccion de derivados de acido glutamico marcados con f-18.
UA106988C2 (uk) Спосіб одержання 1-бензил-3-гідроксиметил-1h-індазолу і його похідних та необхідні проміжні сполуки магнію
CO6430457A2 (es) Proceso para la preparación de amidas del ácido pirazol carboxilico
CR20110208A (es) Proceso para la preparación de benzonorbornenos
UA110626C2 (uk) Спосіб одержання пан-інгібіторів циклінзалежної кінази формули (i), а також проміжні продукти цього процесу одержання
EP2192189A4 (en) PROCESS FOR THE PRODUCTION OF STARCHIC ACID
EA201001362A1 (ru) Хинолины в качестве ингибиторов фарнезилпирофосфатсинтазы
EP2247534A4 (en) PROCESS FOR PREPARING CALCIUM COMPOUNDS
UY34386A (es) Método para la producción de ácido láctico
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
MX2012014118A (es) Metodo para la produccion de ligandos beta amiloide marcados con 18f.
CY1117407T1 (el) Διαχωρισμος των εναντιομερων παραγωγων τριαζινης με χρηση τρυγικου οξεος
MX2012014116A (es) Metodo para la produccion de ligandos beta amiloide marcados con 18f.

Legal Events

Date Code Title Description
HH Correction or change in general
HH Correction or change in general
FA Abandonment or withdrawal